About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
EKSO - Ekso Bionics Holding...| Previous Close | $8.04 | Open | $8.51 |
| Volume | 146.6K | Market Cap | 68.03M |
| Yield | Last Dividend |
| Ekso Bionics to Present at the H.C. Wain... | 01/05/21 |
| RICHMOND, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medic... | |
| Global Medical Robotic System Market Is ... | 11/17/20 |
| Data Bridge Market Research has recently added a concise research on the Medical Robotic System Market to depict valuable insights related to signific... | |
| Ekso Bionics Announces Continued Adoptio... | 11/10/20 |
| RICHMOND, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the ???Company???), an industry leader in exoskeleton?... | |
| Medical Exoskeleton Market 2020 High Dem... | 11/10/20 |
| Data Bridge Market Research has recently added concise research on the Global Medical Exoskeleton Market to depict valuable insights related to signif... | |
| Global Medical Robots Transforming Healt... | 11/06/20 |
| The persuasive Global Medical Robots Transforming Healthcare Market research report provides a comprehensive analysis on the study of industry with re... | |
| Human Augmentation Market 2020-2027: Mar... | 11/05/20 |
| Global Human Augmentation Market Analysis, Size, Share, Outlook and Forecast to 2020-2027 is a professional and in-depth research report on the world?... | |
| Smart Exoskeleton Market Applications, T... | 10/27/20 |
| Allied Market Research published a new report, titled, ???Smart Exoskeleton Market by Component (Sensors, Actuators, Power Source, Control System, and... | |
| (VLDR) (NASDAQ:VLDR) versus Ekso Bionics... | 10/24/20 |
| (VLDR) (NASDAQ:VLDR) and Ekso Bionics (NASDAQ:EKSO) are both auto/tires/trucks companies, but which is the superior stock? We will contrast the two co... | |
| Global Medical Robots Transforming Healt... | 10/22/20 |
| A most recent review on Global Medical Robots Transforming Healthcare Market is led covering different associations of the business from various topog... | |
| Ekso Bionics?? to Report Third Quarter 2... | 10/22/20 |
| RICHMOND, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medic... | |
| COVID-19 UPDATE: Global Medical Exoskele... | 10/22/20 |
| Data Bridge Market Research has recently added a concise research on the Medical Exoskeleton Market - Industry Trends and Forecast to 2026. Medical Ex... | |
| Orthopedic Medical Robots Market New Tec... | 10/20/20 |
| Orthopedic medical robots market is segmented by product, anatomy, application and end user. Global orthopedic medical robots market, based on product... | |
| Medical Exoskeleton Market 2020 Indepth ... | 10/19/20 |
| A most recent review on Medical Exoskeleton Market is led covering different associations of the business from various topographies to think of 100+ p... | |
| Medical Exoskeleton Market 2020 Analysis... | 10/19/20 |
| A DBMR team makes use of simple language and easy to understand statistical images to provide thorough information and in-depth data on the industry a... | |
| Socially Assistive Healthcare Assistive ... | 10/15/20 |
| Socially Assistive Healthcare Assistive Robot Market research report provides essential and knowledgeable insights on the market and details a descrip... | |
| Global Medical Robotic System Market 202... | 10/08/20 |
| DBMR has added a new report titled Global Medical Robotic System market with analysis provides the insights which bring marketplace clearly into the f... | |
| Medical Exoskeleton Market 2020 Incredib... | 10/07/20 |
| To prepare this Medical Exoskeleton Market research report, an array of objectives of market research has been considered. While formulating this mark... | |
| Ekso Bionics Reports Second Quarter 2020... | 07/30/20 |
| RICHMOND, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the ???Company???), an industry leader in exoskeleton?... | |
| Why Ekso Bionics Stock Is Trading Higher... | 06/26/20 |
| Ekso Bionics Holdings (NASDAQ: EKSO ) shares were trading higher Friday on continued strength after the company received FDA clearance to market its E... | |
| Thinking about buying stock in Soligenix... | 06/26/20 |
| NEW YORK, June 26, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNGX, EKSO, SINT, AIM, and NIO. To see how InvestorsOb... | |
| Ekso Bionics News: Why EKSO Stock Is Sky... | 06/25/20 |
| Ekso Bionics (EKSO) news for Thursday concerning approval from the FDA for one of its devices has EKSO stock soaring higher. | |
| Ekso Bionics shares soar after company g... | 06/25/20 |
| Shares of Ekso Bionics Holdings Inc. undefined soared Thursday, after the company said it has received 501 clearance from the U.S. Food and Drug??? | |
| Thinking about buying stock in Ekso Bion... | 06/25/20 |
| NEW YORK, June 25, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EKSO, AAPL, GNC, MSFT, and APVO. To see how InvestorsO... | |
| The Daily Biotech Pulse: Roche Obtains F... | 03/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) ... | |
| The Daily Biotech Pulse: Mesoblast To Te... | 03/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) A... | |
| Ekso Bionics collaboration with Kindred ... | 02/25/20 |
| Ekso Bionics (NASDAQ:EKSO) is up 20% to $0.45/share after announcing a collaboration with Kindred Healthcare to pilot EksoNR - the most clinically use... | |
| Post Acute Medical (PAM) Accelerates Ado... | 02/19/20 |
| ENOLA, Penn. and RICHMOND, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Post Acute Medical, LLC, (PAM), a system of inpatient rehabilitation hospitals, h... | |
| Cantor likes Durect in premarket analyst... | 09/06/19 |
| Durect (DRRX) initiated with Overweight rating and $5 (201% upside) price target at Cantor Fitzgerald. Ekso Bionics Holdings (EKSO) initiated with Ove... | |
| The Daily Biotech Pulse: Genmab-Novartis... | 08/30/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: Mallinkckrodt's... | 08/15/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 14) ... | |
| Buy rating | 10/30/20 |
| HC Wainwright & Co. maintains Buy rating and lowers Price Target from $12.00 to $11.00 | |
| Date | 2020-10-29 (AMC) | Est. (EPS/Rev.) | ($0.39)/ 2.45M |
| Actual (EPS/Rev.) | $-0.32/ $2.90 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| WIDE AWAKE | JOHN KROLIKOWSKI JR | 79.00 % | Follow |
| Technical Swing Picks | Kaffel | 60.00 % | Follow |
| Basura | Monkey Business | 59.00 % | Subscribe |
| Small Cap Trader | James Bills | 52.00 % | Follow |
| R R Investments | Roland Van Rij | 38.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
